Goldman Sachs Knock-Out UCB/ DE000GG8FR05 /
| 7/8/2024 12:50:57 PM | Chg.- | Bid9:52:13 AM | Ask9:52:13 AM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 1.89EUR | - | 1.95 Bid Size: 20,000 |
1.98 Ask Size: 20,000 |
UCB SA | 124.9265 EUR | 12/31/2078 | Call |
GlobeNewswire
6/28
United Community Banks, Inc. Announces Date for Second Quarter 2024 Earnings Release and Conference ...
GlobeNewswire
6/4
Chair of UC Berkeley Nuclear Engineering Department Joins NANO Nuclear Energy as Lead Developer of ‘...
GlobeNewswire
6/4
ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody ...
GlobeNewswire
6/3
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the...
GlobeNewswire
5/9
US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire
5/1
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer
GlobeNewswire
4/30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
4/30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
4/15
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulpha...
GlobeNewswire
4/1
Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire
3/25
Marathon Digital Holdings Releases Industry-Leading Bitcoin Mining Firmware and Control Board
GlobeNewswire
3/5
Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...
GlobeNewswire
3/5
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...
GlobeNewswire
2/28
Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...
GlobeNewswire
2/16
United Community Banks, Inc. Announces Quarterly Cash Dividends on Preferred Stock
GlobeNewswire
2/8
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Ca...
GlobeNewswire
1/22
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilizati...
GlobeNewswire
1/15
ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron...
GlobeNewswire
1/7
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical ...
GlobeNewswire
12/8/2023
General Atomics Brings Inertial Fusion Energy Expertise to Two National Research Hubs
GlobeNewswire
11/14/2023
Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis
GlobeNewswire
11/14/2023
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
GlobeNewswire
11/13/2023
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanom...
